52 related articles for article (PubMed ID: 26345951)
1. Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.
Cao ZH; Yin HP; Jiang N; Yu B
Genet Mol Res; 2015 Aug; 14(3):10145-51. PubMed ID: 26345951
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
Zhang H; Ge J; Hong H; Bi L; Sun Z
World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer.
Tang Y; Zhang R; Li Y; Xu S; Wang H; Xu J; Xiao L; Wang Y; Du J; Huang Y; Su T
BMC Cancer; 2021 Jul; 21(1):842. PubMed ID: 34284736
[TBL] [Abstract][Full Text] [Related]
4. Outcome Definition Influences the Relationship Between Genetic Polymorphisms of
Zazuli Z; Otten LS; Drögemöller BI; Medeiros M; Monzon JG; Wright GEB; Kollmannsberger CK; Bedard PL; Chen Z; Gelmon KA; McGoldrick N; Kitchlu A; Vijverberg SJH; Masereeuw R; Ross CJD; Liu G; Carleton BC; Maitland-van der Zee AH
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31083486
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis.
Metzger R; Warnecke-Eberz U; Alakus H; Kütting F; Brabender J; Vallböhmer D; Grimminger PP; Mönig SP; Drebber U; Hölscher AH; Bollschweiler E
J Gastrointest Surg; 2012 Jan; 16(1):26-34; discussion 34. PubMed ID: 21956434
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.
Yang Z; Fang X; Pei X; Li H
Genet Test Mol Biomarkers; 2013 Sep; 17(9):700-6. PubMed ID: 23909490
[TBL] [Abstract][Full Text] [Related]
7. Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children.
Zhuo ZJ; Liu W; Zhang J; Zhu J; Zhang R; Tang J; Yang T; Zou Y; He J; Xia H
EBioMedicine; 2018 Apr; 30():113-119. PubMed ID: 29544698
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms and pancreatic cancer risk: A PRISMA-compliant systematic review and meta-analysis.
Dai P; Li J; Li W; Qin X; Wu X; Di W; Zhang Y
Medicine (Baltimore); 2019 Aug; 98(32):e16541. PubMed ID: 31393355
[TBL] [Abstract][Full Text] [Related]
9. DNA Repair Genetics and the Risk of Radiation Pneumonitis in Patients With Lung Cancer: A Systematic Review and Meta-analysis.
Yiu WS; Chu TSM; Meng Y; Kong FS
Clin Oncol (R Coll Radiol); 2024 Mar; ():. PubMed ID: 38653664
[TBL] [Abstract][Full Text] [Related]
10. ERCC1 and ERCC2 polymorphisms and adult glioma.
Wrensch M; Kelsey KT; Liu M; Miike R; Moghadassi M; Sison JD; Aldape K; McMillan A; Wiemels J; Wiencke JK
Neuro Oncol; 2005 Oct; 7(4):495-507. PubMed ID: 16212814
[TBL] [Abstract][Full Text] [Related]
11. Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review.
Zazuli Z; Vijverberg S; Slob E; Liu G; Carleton B; Veltman J; Baas P; Masereeuw R; Maitland-van der Zee AH
Front Pharmacol; 2018; 9():1111. PubMed ID: 30319427
[No Abstract] [Full Text] [Related]
12. Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.
Zhang Q; Lv LY; Li BJ; Zhang J; Wei F
Genet Mol Res; 2015 Sep; 14(3):11235-41. PubMed ID: 26400354
[TBL] [Abstract][Full Text] [Related]
13. Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population.
Wu X; Lu W; Jiang C; Zhang D; Zhang W; Cui Y; Zhuo Z; Mei H; Wang Y; Zhang M; Chen S
PLoS One; 2023; 18(5):e0284825. PubMed ID: 37141338
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
Hattinger CM; Casotti C; Patrizio MP; Luppi S; Fantoni L; Scotlandi K; Ibrahim T; Serra M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233089
[TBL] [Abstract][Full Text] [Related]
15. A Novel Overall Survival Prediction Signature Based on Cancer Stem Cell-Related Genes in Osteosarcoma.
Xiao B; Liu L; Chen Z; Li A; Xia Y; Wang P; Xiang C; Zeng Y; Li H
Front Cell Dev Biol; 2021; 9():753414. PubMed ID: 34733853
[No Abstract] [Full Text] [Related]
16. Association of ERCC gene polymorphism with osteosarcoma risk.
Wang G; Li J; Xu X; Gupta RK; Gao X
Afr Health Sci; 2020 Dec; 20(4):1840-1848. PubMed ID: 34394247
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact.
Hattinger CM; Patrizio MP; Luppi S; Serra M
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629971
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population.
Liu D; Liu X
Medicine (Baltimore); 2018 Dec; 97(49):e13358. PubMed ID: 30544402
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
